A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System

키워드

참고문헌 (49)

1. Walsh J, "Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006-2016", BMC Rheumatol, 3, pp.39~ (2019)
2. Braun J, "Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors", Arthritis Rheum, 41, pp.58~67 (1998)
3. Tran TM, "Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats", Arthritis Rheum, 54, pp.1317~1327 (2006)
4. Baeten D, "Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?", Arthritis Rheum, 65, pp.12~20 (2013)
5. Sherlock JP, "IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8-entheseal resident T cells", Nat Med, 18, pp.1069~1076 (2012)
6. Liu CH, "HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis", J Clin Invest, 129, pp.5357~5373 (2019)
7. Colbert RA, "From HLA-B27 to spondyloarthritis : a journey through the ER", Immunol Rev, 233, pp.181~202 (2010)
8. Kingsbury DJ, "Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27 : association with deficiency of endogenous major histocompatibility complex class I expression", Arthritis Rheum, 43, pp.2290~2296 (2000)
9. Liu Y, "Autoantibodies in spondyloarthritis, focusing on anti-CD74 antibodies", Front Immunol, 10, pp.5~ (2019)
10. Taams LS, "IL-17 in the immunopathogenesis of spondyloarthritis", Nat Rev Rheumatol, 14, pp.453~466 (2018)
11. Curry R, "Antibodies to and elevations of beta 2 microglobulin in the serum of ankylosing spondylitis patients", Arthritis Rheum, 25, pp.375~380 (1982)
12. Charrière G, "Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases", Arthritis Rheum, 31, pp.325~332 (1988)
13. Hušáková M, "Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis", Sci Rep, 9, pp.11218~ (2019)
14. Tani Y, "Serum IgA1 and IgA2 subclass antibodies against collagens in patients with ankylosing spondylitis", Scand J Rheumatol, 26, pp.380~382 (1997)
15. Holers VM, "Complement in the initiation and evolution of rheumatoid arthritis", Front Immunol, 9, pp.1057~ (2018)
16. Noris M, "Overview of complement activation and regulation", Semin Nephrol, 33, pp.479~492 (2013)
17. Banda NK, "Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway", J Immunol, 179, pp.4101~4109 (2007)
18. Lofchy LA, "Evaluation of targeting efficiency of joints with anticollagen II antibodies", Mol Pharm, 16, pp.2445~2451 (2019)
19. Abdelaziz MM, "Diagnostic value of anti-CD74 antibodies in early and late axial spondyloarthritis and its relationship to disease activity", Rheumatology(Oxford), 60, pp.263~268 (2021)
20. Kinsella TD, "Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis", J Rheumatol, 2, pp.308~313 (1975)
21. Krauledat PB, "Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica", Rheumatol Int, 5, pp.97~101 (1985)
22. Panayi GS, "Circulating immune complexes in patients with ankylosing spondylitis", Ann Rheum Dis, 39, pp.445~448 (1980)
23. Yang C, "Inhibition of complement retards ankylosing spondylitis progression", Sci Rep, 6, pp.34643~ (2016)
24. Miyakis S, "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)", J Thromb Haemost, 4, pp.295~306 (2006)
25. Bárdos T, "A longitudinal study on an autoimmune murine model of ankylosing spondylitis", Ann Rheum Dis, 64, pp.981~987 (2005)
26. Glant TT, "Proteoglycan-induced arthritis in BALB", c mice. Clinical features and histopathology, 1987, pp.30, 201~212
27. Taurog JD, "Inflammatory disease in HLA-B27 transgenic rats", Immunol Rev, 169, pp.209~223 (1999)
28. Weinreich S, "HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice", Hum Immunol, 42, pp.103~115 (1995)
29. Khare SD, "HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27", human beta2-microglobulin(beta2m)double transgenic mice with disrupted mouse beta2m, 1996, pp.98, 2746~2755
30. Ruutu M, "β-glucan triggers spondylarthritis and Crohn’s disease-like ileitis in SKG mice", Arthritis Rheum, 64, pp.2211~2222 (2012)
31. Taylor SR, "P2X7 deficiency attenuates renal injury in experimental glomerulonephritis", J Am Soc Nephrol, 20, pp.1275~1281 (2009)
32. Banda NK, "Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis", J Immunol, 177, pp.1904~1912 (2006)
33. Tseng HW, "Inflammation-driven bone formation in a mouse model of ankylosing spondylitis : sequential not parallel processes", Arthritis Res Ther, 18, pp.35~ (2016)
34. Banda NK, "Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice", J Immunol, 188, pp.1469~1478 (2012)
35. Neerinckx B, "No evidence for a direct role of HLA-B27 in pathological bone formation in axial SpA", RMD Open, 3, pp.e000451~ (2017)
36. Barczyńska TA, "Coexistence of rheumatoid arthritis and ankylosing spondylitis", Reumatologia, 53, pp.279~285 (2015)
37. Brinch L, "The in-vivo metabolism of C3 in ankylosing spondylitis", Ann Rheum Dis, 41, pp.86~89 (1982)
38. Baeten D, "Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy", Arthritis Res Ther, 7, pp.R359~R369 (2005)
39. Kruithof E, "Synovial histopathology of psoriatic arthritis, both oligo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis", Arthritis Res Ther, 7, pp.R569~R580 (2005)
40. Ji H, "Arthritis critically dependent on innate immune system players", Immunity, 16, pp.157~168 (2002)
41. Korganow AS, "From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins", Immunity, 10, pp.451~461 (1999)
42. Maccioni M, "Arthritogenic monoclonal antibodies from K", BxN mice, 2002, pp.195, 1071~1077
43. Vidarsson G, "IgG subclasses and allotypes : from structure to effector functions", Front Immunol, 5, pp.520~ (2014)
44. Banda NK, "An accidental discovery of a new potential mouse model of the axial spondyloarthritis", J Immunol, 202, pp.133~ (2019)
45. Banda NK, "Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression", J Immunol, 193, pp.2455~2468 (2014)
46. Tani Y, "Autoantibodies to collagens in Japanese patients with ankylosing spondylitis", Clin Exp Rheumatol, 15, pp.295~297 (1997)
47. von Mühlen CA, "Autoantibodies in the diagnosis of systemic rheumatic diseases", Semin Arthritis Rheum, 24, pp.323~358 (1995)
48. Mohan C, "Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?", BMJ, 351, pp.h5079~ (2015)
49. Yoshida M, "Autoimmunity to citrullinated type II collagen in rheumatoid arthritis", Mod Rheumatol, 16, pp.276~281 (2006)

관련 논문AI추천